Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells
A series of novel C4-C7-tethered biscoumarin derivatives (<b>12a</b>–<b>e</b>) linked through piperazine moiety was designed, synthesized, and evaluated biological/therapeutic potential. Biscoumarin <b>12d</b> was found to be the most effective inhibitor of both a...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/8/3830 |
id |
doaj-8c388bb7284d4588979e48d7f965924d |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Monika Hudáčová Slávka Hamuľaková Eva Konkoľová Rastislav Jendželovský Jana Vargová Juraj Ševc Peter Fedoročko Ondrej Soukup Jana Janočková Veronika Ihnatova Tomáš Kučera Petr Bzonek Nikola Novakova Daniel Jun Lucie Junova Jan Korábečný Kamil Kuča Mária Kožurková |
spellingShingle |
Monika Hudáčová Slávka Hamuľaková Eva Konkoľová Rastislav Jendželovský Jana Vargová Juraj Ševc Peter Fedoročko Ondrej Soukup Jana Janočková Veronika Ihnatova Tomáš Kučera Petr Bzonek Nikola Novakova Daniel Jun Lucie Junova Jan Korábečný Kamil Kuča Mária Kožurková Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells International Journal of Molecular Sciences biscoumarin Alzheimer’s disease blood–brain barrier cholinesterase antiproliferative activity A549 |
author_facet |
Monika Hudáčová Slávka Hamuľaková Eva Konkoľová Rastislav Jendželovský Jana Vargová Juraj Ševc Peter Fedoročko Ondrej Soukup Jana Janočková Veronika Ihnatova Tomáš Kučera Petr Bzonek Nikola Novakova Daniel Jun Lucie Junova Jan Korábečný Kamil Kuča Mária Kožurková |
author_sort |
Monika Hudáčová |
title |
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells |
title_short |
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells |
title_full |
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells |
title_fullStr |
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells |
title_full_unstemmed |
Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells |
title_sort |
synthesis of new biscoumarin derivatives, in vitro cholinesterase inhibition, molecular modelling and antiproliferative effect in a549 human lung carcinoma cells |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-04-01 |
description |
A series of novel C4-C7-tethered biscoumarin derivatives (<b>12a</b>–<b>e</b>) linked through piperazine moiety was designed, synthesized, and evaluated biological/therapeutic potential. Biscoumarin <b>12d</b> was found to be the most effective inhibitor of both acetylcholinesterase (AChE, IC<sub>50</sub> = 6.30 µM) and butyrylcholinesterase (BChE, IC<sub>50</sub> = 49 µM). Detailed molecular modelling studies compared the accommodation of ensaculin (well-established coumarin derivative tested in phase I of clinical trials) and <b>12d</b> in the human recombinant AChE (<i>h</i>AChE) active site. The ability of novel compounds to cross the blood–brain barrier (BBB) was predicted with a positive outcome for compound <b>12e</b>. The antiproliferative effects of newly synthesized biscoumarin derivatives were tested in vitro on human lung carcinoma cell line (A549) and normal colon fibroblast cell line (CCD-18Co). The effect of derivatives on cell proliferation was evaluated by MTT assay, quantification of cell numbers and viability, colony-forming assay, analysis of cell cycle distribution and mitotic activity. Intracellular localization of used derivatives in A549 cells was confirmed by confocal microscopy. Derivatives <b>12d</b> and <b>12e</b> showed significant antiproliferative activity in A549 cancer cells without a significant effect on normal CCD-18Co cells. The inhibition of <i>h</i>AChE/human recombinant BChE (<i>h</i>BChE), the antiproliferative activity on cancer cells, and the ability to cross the BBB suggest the high potential of biscoumarin derivatives. Beside the treatment of cancer, <b>12e</b> might be applicable against disorders such as schizophrenia, and <b>12d</b> could serve future development as therapeutic agents in the prevention and/or treatment of Alzheimer’s disease. |
topic |
biscoumarin Alzheimer’s disease blood–brain barrier cholinesterase antiproliferative activity A549 |
url |
https://www.mdpi.com/1422-0067/22/8/3830 |
work_keys_str_mv |
AT monikahudacova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT slavkahamulakova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT evakonkolova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT rastislavjendzelovsky synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT janavargova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT jurajsevc synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT peterfedorocko synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT ondrejsoukup synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT janajanockova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT veronikaihnatova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT tomaskucera synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT petrbzonek synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT nikolanovakova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT danieljun synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT luciejunova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT jankorabecny synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT kamilkuca synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells AT mariakozurkova synthesisofnewbiscoumarinderivativesinvitrocholinesteraseinhibitionmolecularmodellingandantiproliferativeeffectina549humanlungcarcinomacells |
_version_ |
1724164102685720576 |
spelling |
doaj-8c388bb7284d4588979e48d7f965924d2021-04-07T23:05:19ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01223830383010.3390/ijms22083830Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma CellsMonika Hudáčová0Slávka Hamuľaková1Eva Konkoľová2Rastislav Jendželovský3Jana Vargová4Juraj Ševc5Peter Fedoročko6Ondrej Soukup7Jana Janočková8Veronika Ihnatova9Tomáš Kučera10Petr Bzonek11Nikola Novakova12Daniel Jun13Lucie Junova14Jan Korábečný15Kamil Kuča16Mária Kožurková17Department of Biochemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaDepartment of Organic Chemistry, Institute of Chemical Sciences, Faculty of Science, Pavol Jozef Šafárik University in Košice, Moyzesova 11, 040 01 Kosice, SlovakiaDepartment of Biochemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaDepartment of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaDepartment of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaDepartment of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaDepartment of Cellular Biology, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicBiomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicBiomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicDepartment of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 500 05 Hradec Kralove, Czech RepublicBiomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech RepublicDepartment of Biochemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Šrobárova 2, 041 54 Košice, SlovakiaA series of novel C4-C7-tethered biscoumarin derivatives (<b>12a</b>–<b>e</b>) linked through piperazine moiety was designed, synthesized, and evaluated biological/therapeutic potential. Biscoumarin <b>12d</b> was found to be the most effective inhibitor of both acetylcholinesterase (AChE, IC<sub>50</sub> = 6.30 µM) and butyrylcholinesterase (BChE, IC<sub>50</sub> = 49 µM). Detailed molecular modelling studies compared the accommodation of ensaculin (well-established coumarin derivative tested in phase I of clinical trials) and <b>12d</b> in the human recombinant AChE (<i>h</i>AChE) active site. The ability of novel compounds to cross the blood–brain barrier (BBB) was predicted with a positive outcome for compound <b>12e</b>. The antiproliferative effects of newly synthesized biscoumarin derivatives were tested in vitro on human lung carcinoma cell line (A549) and normal colon fibroblast cell line (CCD-18Co). The effect of derivatives on cell proliferation was evaluated by MTT assay, quantification of cell numbers and viability, colony-forming assay, analysis of cell cycle distribution and mitotic activity. Intracellular localization of used derivatives in A549 cells was confirmed by confocal microscopy. Derivatives <b>12d</b> and <b>12e</b> showed significant antiproliferative activity in A549 cancer cells without a significant effect on normal CCD-18Co cells. The inhibition of <i>h</i>AChE/human recombinant BChE (<i>h</i>BChE), the antiproliferative activity on cancer cells, and the ability to cross the BBB suggest the high potential of biscoumarin derivatives. Beside the treatment of cancer, <b>12e</b> might be applicable against disorders such as schizophrenia, and <b>12d</b> could serve future development as therapeutic agents in the prevention and/or treatment of Alzheimer’s disease.https://www.mdpi.com/1422-0067/22/8/3830biscoumarinAlzheimer’s diseaseblood–brain barriercholinesteraseantiproliferative activityA549 |